Purpose + Experience = Results.

Wilkinson Walsh has one purpose: winning high-stakes trials.

Winning Strategies

At the heart of every case is a compelling story. From the beginning of every case, we work to uncover that story so that we can convey it to the judge and jury in a clear, concise, and compelling way. Our results speak for themselves.

Together, we have successfully tried over 130 cases to juries and judges across the country, from Los Angeles, San Diego, San Jose, and San Francisco to New York, Washington, Philadelphia, and Boston—and many places in between.

What We Do

Latest News

Wilkinson Walsh Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers

December 30, 2019

WASHINGTON –Wilkinson Walsh enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.

Wilkinson Walsh’s Kosta Stojilkovic Appointed to the Judicial Conference Committee on Rules of Practice and Procedure of the United States

December 4, 2019

WASHINGTON -- Wilkinson Walsh Partner Kosta Stojilkovic was appointed by Chief Justice John G. Roberts, Jr. to a three-year term on the Judicial Conference Committee on Rules of Practice and Procedure. The “Standing Committee,” as it is commonly known, reviews, drafts, and recommends new rules governing practice and procedure in federal courts. Five advisory committees supplement the Standing Committee and propose changes to appellate, bankruptcy, civil, criminal, and evidence rules.

Alexandra Walsh Named Law 360 Trials MVP of the Year

November 18, 2019

WASHINGTON – Wilkinson Walsh Founding Partner Alexandra Walsh was named one of Law360’s 2019 Trial MVPs of the Year. The award recognizes Walsh for leading “trial teams to a string of crucial victories for Bayer AG this year, persuading juries to reject a certified class action attacking the company’s One A Day vitamins as well as suits over its blood thinner Xarelto.”